RxSight (RXST) Earnings Analysis
RxSight (RXST) has no confirmed upcoming earnings date. Last quarter (2026-02-25) it beat with EPS -0.22 USD vs -0.3347 USD est (+34.3%). It has beaten estimates in 4/4 recent quarters (100%). Trailing P/E -4.77.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does RXST next report earnings?
No confirmed upcoming earnings date is currently scheduled for RXST. This page updates as the calendar is published.
RXST earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-25 | -0.22 USD | -0.3347 USD | +34.3% | Beat |
| 2025-08-07 | -0.08 USD | -0.1 USD | +20% | Beat |
| 2024-11-07 | -0.16 USD | -0.25 USD | +36% | Beat |
| 2024-08-05 | -0.16 USD | -0.22 USD | +27.3% | Beat |
Beat rate: 4/4 (100%) over reported quarters with consensus data.
RXST valuation and analyst view
| Trailing P/E | -4.77 |
|---|---|
| Trailing EPS | -1.12906 USD |
| Price / book | 0.83 |
| Dividend yield | 0.00% |
| Market cap | 0.22B |
| Analyst consensus | Hold (3 buy / 7 hold / 2 sell) |
| Avg price target | 8.75 USD |
Related research pages
Frequently asked questions
When is RxSight (RXST)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for RXST. This page updates as the calendar is published.
Did RXST beat earnings last quarter?
In its 2026-02-25 report, RXST posted EPS of -0.22 USD versus a -0.3347 USD estimate — a beat of 34.3%.
What is RXST's earnings track record?
Over the last 4 reported quarters with consensus data, RXST beat estimates 4 times (100%).
What is RXST's current P/E ratio and EPS?
RXST trades at a trailing P/E of -4.77 on trailing EPS of -1.1290581466034928 USD.
What do analysts rate RXST?
Analyst consensus is "Hold" across 12 ratings (0 strong buy, 3 buy, 7 hold, 2 sell, 0 strong sell). Average 12-month price target: 8.75 USD.